home / stock / isr / isr news

ISR News and Press, IsoRay Inc. From 02/09/21

Stock Information
Company Name: IsoRay Inc.
Stock Symbol: ISR
Market: NYSE
Menu
ISR ISR Quote ISR Short ISR News ISR Articles ISR Message Board
Get ISR Alerts

News, Short Squeeze, Breakout and More Instantly...
ISR - Isoray Announces Second Quarter Fiscal 2021 Financial Results

Revenue Increased 7% Year-Over-Year Non-Prostate Brachytherapy Revenue Increased 92% Year-Over-Year RICHLAND, Wash., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding tre...
ISR - Isoray To Announce Second Quarter Fiscal 2021 Financial Results on February 9, 2021

RICHLAND, Wash., Feb. 05, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced that it will host a conference call to discuss its fin...

ISR - AVXL, GME, ATOS and BTU among midday movers

Gainers: ATA Creativity Global (AACG) +204%.Anavex Life Sciences (AVXL) +81%.Lizhi (LIZI) +76%.CPS Technologies (CPSH) +48%.Annovis Bio (ANVS) +43%.Sify Technologies (SIFY) +42%.Tian Ruixiang (TIRX) +40%.Cyclerion Therapeutics (CYCN) +39%.Cyclo Therapeutics (CYTH) +33%.Ato...

ISR - Anavex Life Sciences, Annovis Bio leads healthcare gainers; Tyme Technologies, Isoray among major losers

Gainers: Anavex Life Sciences (AVXL) +94%, Annovis Bio (ANVS) +50%, Atossa Therapeutics (ATOS) +40%, Cyclerion Therapeutics (CYCN) +40%, Cyclo Therapeutics (CYTH) +33%.Losers: Tyme Technologies (TYME) -36%, Isoray (ISR) -19%, Lannett...
ISR - Isoray under pressure on raising $45M capital through equity offering

Isoray (ISR) down 19.6% premarket on pricing public offering of 36M common shares at $1.25/share, for gross proceeds of ~$45M. The offering is expected to close on February 8.Underwriters' over-allotment is an additional 15% of the offering.Proceeds will be used to fund operati...

ISR - Isoray Announces Pricing of $45 Million Public Offering

RICHLAND, Wash., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, announced the pricing of its public offering of 36,000,000 shares of its common st...

ISR - Isoray in red on launching stock offering

Isoray (ISR) traded 10% down in after hours trade after it announced to offer and sell shares in an underwritten public offering; underwriters granted 30-day option to purchase up to an additional 15% of the shares.Offer size, terms not yet disclosed.Proceeds to be used for fun...
ISR - Isoray Announces Proposed Underwritten Public Offering

RICHLAND, Wash., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR) (“Isoray” or the “Company”), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced that it in...

ISR - IBM, GSAT among premarket losers

Senseonics Holdings (SENS) -16% after raising size of stock offering.Global Ship Lease (GSL) -14% after announcing public offering.Globalstar (GSAT) -13% after Morgan Stanley cuts to underweight on valuation.Broadwind (BWEN) -13% after guiding Q4 revenu...

ISR - NFLX, TELL, CLBS, and FUTU among notable pre-market gainers

Caladrius Biosciences (CLBS) +120%.Aptorum Group (APM) +61% as Canada approves early-stage infection drug trial.Steel Connect (STCN) +54%.Dare Bioscience (DARE) +39%.ENDRA Life Sciences (NDRA) +36%.Lineage Cell Therapeutics (LCTX) +34%.Inuvo (INUV) +33%.eMagin Corporation (EMAN) +28...
Previous 10 Next 10